MCID: BLR001
MIFTS: 52

Biliary Atresia malady

Categories: Rare diseases, Gastrointestinal diseases, Liver diseases

Aliases & Classifications for Biliary Atresia

About this section

Aliases & Descriptions for Biliary Atresia:

Name: Biliary Atresia 11 48 27 50 39 13 68
Non-Syndromic Biliary Atresia 48
Biliary Atresia, Congenital 11
 
Congenital Biliary Atresia 11
Atresia of Bile Duct 11

Classifications:



External Ids:

Disease Ontology11 DOID:13608
ICD1030 Q44.2
ICD9CM32 751.61
MeSH39 D001656

Summaries for Biliary Atresia

About this section
Wikipedia:71 Biliary atresia, also known as extrahepatic ductopenia and progressive obliterative cholangiopathy, is a... more...

MalaCards based summary: Biliary Atresia, also known as non-syndromic biliary atresia, is related to biliary atresia, extrahepatic and ichthyosis congenita biliary atresia, and has symptoms including icterus An important gene associated with Biliary Atresia is SLC10A1 (Solute Carrier Family 10 Member 1), and among its related pathways are Farnesoid X Receptor Pathway and Drug Induction of Bile Acid Pathway. Affiliated tissues include liver, t cells and bone, and related mouse phenotypes are digestive/alimentary and liver/biliary system.

Disease Ontology:11 A cholestasis characterized by blockage of the ducts that carry bile from the liver to the gallbladder.

Related Diseases for Biliary Atresia

About this section

Diseases related to Biliary Atresia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 134)
idRelated DiseaseScoreTop Affiliating Genes
1biliary atresia, extrahepatic12.3
2ichthyosis congenita biliary atresia11.9
3biliary atresia intrahepatic non syndromic form11.9
4biliary atresia intrahepatic syndromic form11.9
5biliary atresia with splenic malformation syndrome11.9
6hepatoblastoma11.3
7lambert syndrome11.2
8hyperbiliverdinemia10.9
9bile duct disease10.9
10hepatitis10.5
11choledochal cyst10.3
12miliaria10.2CTGF, TGFB1
13aphthous stomatitis10.2ALB, CTGF, TGFB1
14agammaglobulinemia 610.2ALB, CTGF, TGFB1
15acute monocytic leukemia10.2ALB, GPT, HGF
16cholestasis10.2
17cholangitis10.2
18paranasal sinus sarcoma10.2ALB, GPT, HGF
19zika fever10.2CTGF, TGFB1, TIMP1
20fiedler's myocarditis10.2ALB, GPT, TGFB1
21acute necrotizing encephalitis10.2ALB, CTGF, TGFB1
22cholera10.2CTGF, TGFB1, TIMP1
23noninfectious dermatoses of eyelid10.1ALB, GPT, TGFB1
24germ cell and embryonal cancer10.1CTGF, TGFB1, TIMP1
25henoch-schoenlein purpura10.1ALB, TGFB1, TIMP1
26hemorrhagic cystitis10.1CTGF, HGF, TGFB1
27borderline leprosy10.1ALB, GPT, NR1H4
28calcinosis10.1ALB, CTGF, TGFB1
29burns10.1MMP7, TGFB1, TIMP1
30albinism, oculocutaneous, type ia10.1CTGF, HGF, TGFB1, TIMP1
31hereditary spastic paraplegia10.1ALB, GPT, SLC10A1, TGFB1
32renal tubular acidosis10.1CTGF, HGF, TGFB1, TIMP1
33lymphoid leukemia10.1ALB, GPT, HGF, TGFB1
34benign focal seizures of adolescence10.1MMP7, TIMP1
35geleophysic dysplasia 210.1CTGF, TGFB1
36esophagitis10.1
37ascending cholangitis10.1
38heart aneurysm10.0ALB, NR1H4, SLC10A1
39cholestasis, intrahepatic, of pregnancy, 110.0JAG1, NR1H4, SLC10A2
40alagille syndrome10.0
41portal hypertension10.0
42situs inversus10.0
43ringed hair10.0GPC1, GPT, JAG1, SLC10A1
44trichodysplasia-xeroderma10.0ALB, SPP1
45proctitis10.0ALB, MMP7, TGFB1
46hepatocellular carcinoma10.0
47neuroectodermal endocrine syndrome9.9CTGF, SPP1, TGFB1, TIMP1
48chronic rheumatic pericarditis9.9ALB, JAG1, NR1H4, SLC10A2
49liver disease9.9
50thrombosis9.9

Graphical network of the top 20 diseases related to Biliary Atresia:



Diseases related to biliary atresia

Symptoms & Phenotypes for Biliary Atresia

About this section

UMLS symptoms related to Biliary Atresia:


icterus

MGI Mouse Phenotypes related to Biliary Atresia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053819.0ALB, CTGF, JAG1, MMP7, NR1H4, SLC10A2
2MP:00053708.7ALB, HGF, JAG1, NR1H4, SLC10A2, SPP1
3MP:00053858.2ADD3, CTGF, HGF, JAG1, MMP7, NR1H4
4MP:00020068.1ALB, GPC1, MMP7, NR1H4, SPP1, TGFB1
5MP:00053787.6CTGF, HGF, JAG1, MMP7, NR1H4, SLC10A2
6MP:00053766.9ALB, CTGF, GPC1, JAG1, MMP7, NR1H4
7MP:00053976.8ADD3, GPC1, GPT, HGF, JAG1, MMP7

Drugs & Therapeutics for Biliary Atresia

About this section

Drugs for Biliary Atresia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 76)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Meloxicamapproved, vet_approvedPhase 48171125-38-75281106, 54677470
Synonyms:
(3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1
133687-22-6
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
4-hydroxy-2-mehtyl-N-(5-mehtyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
71125-38-7
AC-1325
AC1NQY12
AC1Q3XZW
AKOS000279442
Abbott brand of meloxicam
Almirall brand of meloxicam
Apo-meloxicam
Bio-0826
Boehringer Ingelheim brand of meloxicam
C065757
C08169
C14H13N3O4S2
CCRIS 9139
CHEMBL599
CID5281106
Co Meloxicam
D00969
DB00814
Dom-meloxicam
Europharma brand of meloxicam
FT-0082769
Gen-meloxicam
HMS1922D19
HMS2089B18
I06-0490
LS-40538
M1959
Masflex
 
Meloxicam
Meloxicam (JAN/USAN/INN)
Meloxicam [USAN:BAN:INN]
Meloxicamum
Meloxicamum [Latin]
Meloxicamum [latin]
Meloxivet
Metacam
Mobec
Mobic
Mobic (TN)
Mobic, Metacam, Parocin, Meloxicam
Mobicox
MolPort-002-885-839
Movalis
Movatec
Movicox
Méloxicam
Novo-meloxicam
PHL-meloxicam
PMS-meloxicam
Parocin
Promeco brand of meloxicam
Ratio-meloxicam
S1734_Selleck
SPECTRUM1504150
STK620505
Squibb brand of meloxicam
TL8005001
Tenaron
UH-AC 62XX
UHAC-62XX
UNII-VG2QF83CGL
UNII-vg2qf83cgl
Uticox
meloxicam
miloxicam
reumoxicam
2Anti-Inflammatory AgentsPhase 4, Phase 310729
3AnalgesicsPhase 411733
4Peripheral Nervous System AgentsPhase 423689
5Cyclooxygenase InhibitorsPhase 42870
6Liver ExtractsPhase 4, Phase 24067
7Cyclooxygenase 2 InhibitorsPhase 4624
8Anti-Inflammatory Agents, Non-SteroidalPhase 44443
9Analgesics, Non-NarcoticPhase 46501
10Antirheumatic AgentsPhase 410956
11
Methylprednisoloneapproved, vet_approvedPhase 3119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
12
Prednisoloneapproved, vet_approvedPhase 3119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
13Methylprednisolone HemisuccinatePhase 31193
14Prednisolone hemisuccinatePhase 31193
15Methylprednisolone acetatePhase 31193
16Prednisolone phosphatePhase 31193
17Prednisolone acetatePhase 31193
18Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 313168
19Antineoplastic Agents, HormonalPhase 35592
20Hormone AntagonistsPhase 313180
21glucocorticoidsPhase 35103
22HormonesPhase 314415
23
Pentoxifyllineapproved, investigationalPhase 21026493-05-64740
Synonyms:
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
AKOS000541484
Agapurin
Agapurin Retard
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL-191
BL191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT-0201
EHT-201
EHT0201
EINECS 229-374-5
EU-0100936
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
Hemovas
I06-1592
IDI1_000729
IN1161
Ikomio
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
LS-149385
 
Lopac-P-1784
Lopac0_000936
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
PENTOXYPHYLINE
PNX
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
Pentoxyphyllin
Pentoxyphylline
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Prestwick_608
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
SPECTRUM1503611
SR-01000075641-4
STK177321
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
Spectrum_001444
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
cis-9-Octadecenoyl coenzyme A
pentoxifylline
24
BilirubinPhase 2116635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
25Protective AgentsPhase 27443
26Platelet Aggregation InhibitorsPhase 22516
27Immunoglobulins, IntravenousPhase 1, Phase 2333
28AntibodiesPhase 1, Phase 26394
29Rho(D) Immune GlobulinPhase 1, Phase 2326
30gamma-GlobulinsPhase 1, Phase 2326
31ImmunoglobulinsPhase 1, Phase 26394
32Parenteral Nutrition SolutionsPhase 2160
33Fat Emulsions, IntravenousPhase 297
34Vasodilator AgentsPhase 23543
35AntioxidantsPhase 23050
36Soybean oil, phospholipid emulsionPhase 276
37Pharmaceutical SolutionsPhase 28192
38Phosphodiesterase InhibitorsPhase 21289
39Radiation-Protective AgentsPhase 2480
40Omega 3 Fatty AcidNutraceuticalPhase 21018
41Soy BeanNutraceuticalPhase 2554
42
VancomycinapprovedPhase 13321404-90-6441141, 14969
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
1404-90-6
1404-93-9 (hydrochloride)
64685-75-2 (sulfate)
AC1L24VU
AC1L9AMI
AC1Q29OH
BIDD:GT0353
C06689
C66H75Cl2N9O24
CHEBI:28001
CHEMBL262777
CID14969
CID441141
CID5311496
CID6426898
CID6917992
D00212
DB00512
EINECS 215-772-6
HSDB 3262
LMPK14000004
 
LS-161387
Lopac0_001267
MolPort-001-794-649
NCGC00162383-02
Prestwick0_000497
Prestwick1_000497
Prestwick2_000497
SPBio_002314
UNII-6Q205EH1VU
VAN
VANCOMYCIN
Vancocin
Vancocin (TN)
Vancocin HCL
Vancomicina
Vancomicina [INN-Spanish]
Vancomycin
Vancomycin (USP)
Vancomycin HCL
Vancomycin [USAN:INN:BAN]
Vancomycine
Vancomycine [INN-French]
Vancomycinum
Vancomycinum [INN-Latin]
nchembio.350-comp1
43Anti-Bacterial AgentsPhase 111226
44Anti-Infective AgentsPhase 122062
45
Desfluraneapproved15057041-67-542113
Synonyms:
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane
1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
57041-67-5
AC1L274J
AC1Q4ICY
C07519
C3H2F6O
CHEBI:4445
CHEMBL1200733
CID42113
D00546
DB01189
DESFLURANE
Desflurane
 
Desflurane (JAN/USP/INN)
Desflurane [USAN:INN]
Desflurano
Desflurano [INN-Spanish]
Desfluranum
Desfluranum [INN-Latin]
Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
I 653
I-653
I653
LS-65505
MolPort-001-776-387
PC6781E
Suprane
Suprane (TN)
UNII-CRS35BZ94Q
difluoromethyl 1,2,2,2-tetrafluoroethyl ether
r-e 236ea1
46
Magnesium Sulfateapproved, vet_approved1797487-88-924083
Synonyms:
(C10-C16) Alkylalcohol sulfuric acid, magnesium salt
00627_FLUKA
10028-26-9
10034-99-8 (heptahydrate)
13143_RIEDEL
13143_SIAL
139939-75-6
18939-43-0
203726_ALDRICH
208094_SIAL
34276_FLUKA
34276_RIEDEL
38146_FLUKA
38146_RIEDEL
63126_FLUKA
63136_FLUKA
63136_SIAL
63139_FLUKA
63139_SIAL
68081-97-0
7487-88-9
AC1L2N76
AC1LAX36
AC1Q1U66
AI3-02029
Bitter salt
C10-C16 Alkyl alcohol sulfuric acid magnesium salt
CCRIS 8411
CHEBI:32599
CID24083
CPD0-2390
Caswell No. 534
D008278
DB00653
EINECS 231-298-2
EINECS 233-073-4
EINECS 242-691-3
EINECS 268-365-0
EPA Pesticide Chemical Code 050503
Epsom salt
HSDB 664
Hair salt
Heptahydrate Magnesium Sulfate
Kieserite [as monohydrate]
LS-88605
M2643_SIGMA
M3409_SIGMA
 
M7506_SIAL
M8150_SIGMA
MAGNESIUM SULFATE
Magnesium Sulfate In Plastic Container
Magnesium Sulfate, Heptahydrate
Magnesium Sulphate Hydrate
Magnesium bisulfate
Magnesium hydrogensulphate
Magnesium sulfate
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulfate dried
Magnesium sulfate heptahydrate
Magnesium sulfate hexahydrate
Magnesium sulfate in dextrose 5% in plastic container
Magnesium sulfate solution
Magnesium sulphate
Magnesium sulphate anhydrous
Magnesium sulphate dried
Magnesium sulphate heptahydrate
Magnesium(II) sulfate
Magnesium(ii) sulfate
Magnesiumsulfat
MgSO4
MolPort-003-925-000
NSC 146179
OT-S
OT-S (drying agent)
SDA 15-062-07
Sal Angalis
Sal De sedlitz
Sal amarum
Sal anglicum
Sal catharticum
Sal seidlitense
Salts of england
Sel d'angleterre
Sulfate, Magnesium
Sulfuric acid magnesium salt
Sulfuric acid magnesium salt (1:1)
Sulfuric acid magnesium salt (VAN)
Sulfuric acid, C10-16 alkyl ester, magnesium salt
Sulfuric acid, magnesium salt
Sulfuric acid, magnesium salt (1:1)
Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts
Tomix OT
UNII-DE08037SAB
UNII-ML30MJ2U7I
magnesium(2+) ion sulfate
47
Sevofluraneapproved, vet_approved50828523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
48
Isofluraneapproved, vet_approved17126675-46-73763
Synonyms:
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether
2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane
2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane
26675-46-7
AC-154802
AC1L1GNN
AErrane (Veterinary)
Aerrane
BRN 1852087
C07518
CCRIS 3043
CHEBI:6015
CHEMBL1256
CID3763
Compound 469
D00545
D007530
DB00753
EINECS 247-897-7
Ethane
Ether, 1-chloro-2,2,2-trifluoroethyl difluoromethyl
 
Forane
Forane (TN)
Forene
I14-1303
IsoFlo
Isoflurane
Isoflurane (JP15/USP/INN)
Isoflurane [Anaesthetics, volatile]
Isoflurane [USAN:BAN:INN:JAN]
Isoflurane [USAN:INN:BAN:JAN]
Isoflurane [Usan:Ban:Inn:Jan]
Isoflurano
Isoflurano [INN-Spanish]
Isofluranum
Isofluranum [INN-Latin]
Jsp005223
LS-7462
MolPort-000-153-606
NCGC00181037-01
R-E 235dal
ST51041445
UNII-CYS9AKD70P
isoflurane
49
Neomycinapproved, vet_approved501404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
 
Framygen
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
50
Pancrelipaseapproved97053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)

Interventional clinical trials:

(show all 28)
idNameStatusNCT IDPhase
1Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary AtresiaCompletedNCT02298218Phase 4
2RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.Unknown statusNCT00539565Phase 3
3Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary AtresiaCompletedNCT01854827Phase 1, Phase 2
4Pentoxifylline Therapy in Biliary AtresiaRecruitingNCT01774487Phase 2
5Compassionate Use of Omegaven in ChildrenRecruitingNCT02370251Phase 2
6Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinCompletedNCT01322386Phase 1
7Treating Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinRecruitingNCT02137668Phase 1
8Evaluation of Immune Function in Biliary Atresia Children With Prolonged JaundiceUnknown statusNCT00155194
9Survival With Own Liver of Conventional Versus Laparoscopic Kasai for Biliary AtresiaCompletedNCT01063699
10Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai PortoenterostomyCompletedNCT00166868
11Biliary Atresia, Hepatic Buffer Response and SevofluraneCompletedNCT02471209
12Maternal Microchimerism in Lymph Nodes of Infants With Biliary Atresia at Time of Kasai's OperationCompletedNCT02292862
13A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following PortoenterostomyCompletedNCT00294684
14The Comparison of Desflurane and Sevoflurane on Postoperative Recovery and Hepatic Function of Biliary Atresia Patients During Kasai OperationCompletedNCT01443572
15the Correlation Between Non-invasive Indicators in Patients With Biliary AtresiaCompletedNCT02848573
16Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver DiseaseCompletedNCT00007033
17Biliary Atresia Study in Infants and ChildrenRecruitingNCT00345553
18Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary AtresiaRecruitingNCT02652533
19Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Following the Kasai Hepatoportoenterostomy for Biliary AtresiaRecruitingNCT01745991
20Biliary Atresia Research ConsortiumRecruitingNCT00061828
21Clinical and Basic Study for Pediatric Liver TransplantationRecruitingNCT02503384
22Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA CohortRecruitingNCT01862211
23Shear Wave Sonoelastography in Pediatric Liver FibrosisRecruitingNCT02372682
24Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)RecruitingNCT00571272
25Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver DiseaseAvailableNCT03072667
26FibroScan™ in Pediatric Cholestatic Liver Disease Study ProtocolEnrolling by invitationNCT02922751
27Transfusion Strategies for Pediatric Liver TransplantationNot yet recruitingNCT02951013
28Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in InfantsTerminatedNCT01062815

Search NIH Clinical Center for Biliary Atresia


Cochrane evidence based reviews: biliary atresia

Genetic Tests for Biliary Atresia

About this section

Genetic tests related to Biliary Atresia:

id Genetic test Affiliating Genes
1 Biliary Atresia27

Anatomical Context for Biliary Atresia

About this section

MalaCards organs/tissues related to Biliary Atresia:

36
Liver, T cells, Bone, Testes, Nk cells, Pancreas, Neutrophil

Publications for Biliary Atresia

About this section

Articles related to Biliary Atresia:

(show top 50)    (show all 764)
idTitleAuthorsYear
1
Quality of Life and Parental Worrying in A National Cohort of Biliary Atresia Children Living with Their Native Livers. (28060195)
2017
2
Embryonic cholecystitis and defective gallbladder contraction in the Sox17-haploinsufficient mouse model of biliary atresia. (28432216)
2017
3
Outcomes of laparoscopic Kasai portoenterostomy for biliary atresia: A systematic review. (28007417)
2017
4
Achondroplasia and Biliary Atresia: A Rare Association and Review of Literature. (28497003)
2017
5
Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia. (27862929)
2017
6
MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis. (28083843)
2017
7
Adjuvant steroid treatment following Kasai portoenterostomy and clinical outcomes of biliary atresia patients: an updated meta-analysis. (27830578)
2017
8
Cystic Biliary Atresia and Choledochal Cysts are Distinct Histopathologic Entities. (28079575)
2017
9
Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia. (28052132)
2017
10
Liver stiffness measurements with supersonic shear wave elastography in the diagnosis of biliary atresia: a comparative study with grey-scale US. (28083694)
2017
11
Newborn Screening for Biliary Atresia - Bilirubin or Bust? (27101537)
2016
12
Prognostic values of serum bilirubin at 7th day post-Kasai for survival with native livers in patients with biliary atresia. (27476151)
2016
13
Hepatic pathology of biliary atresia: A new comprehensive evaluation method using liver biopsy. (27210782)
2016
14
Long-term outcomes after revision of Kasai portoenterostomy for biliary atresia. (27591751)
2016
15
Loss of a Candidate Biliary Atresia Susceptibility Gene, add3a, Causes Biliary Developmental Defects in Zebrafish. (27526058)
2016
16
Newborn Bilirubin Screening for Biliary Atresia. (27509119)
2016
17
Interleukin-17 in a Mouse Model of Biliary Atresia and in Livers of Patients: The Study Control Matters. (27140493)
2016
18
MicroRNA-499 Rs3746444 polymorphism and biliary atresia. (26795543)
2016
19
Pediatric Liver Transplantation in Sickle Cell Anemia: A Case of Extrahepatic Biliary Atresia. (27169716)
2016
20
Silver nanoparticle treatment ameliorates biliary atresia syndrome in rhesus rotavirus inoculated mice. (27890655)
2016
21
Health-Related Quality of Life in Children with Biliary Atresia Living with Native Livers. (27125347)
2016
22
Diagnostic and Prognostic Significance of Various Histopathological Features in Extrahepatic Biliary Atresia. (27504296)
2016
23
Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia. (27462066)
2016
24
Expression of transforming growth factor-I^1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue. (26909983)
2016
25
The dendritic cell-Th17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia. (27641439)
2016
26
Incidence of biliary atresia associated congenital malformations: A retrospective multicenter study in China. (27210725)
2016
27
Diffusion Tensor Imaging for Evaluating Biliary Atresia in Infants and Neonates. (27992499)
2016
28
Common genetic variants of GPC1 gene reduce risk of biliary atresia in a Chinese population. (27373597)
2016
29
Idiopathic neonatal hepatitis or extrahepatic biliary atresia? The role of liver biopsy. (27651555)
2016
30
Infant Stool Color Card Screening Helps Reduce the Hospitalization Rate and Mortality of Biliary Atresia: A 14-Year Nationwide Cohort Study in Taiwan. (27015203)
2016
31
Elevation of serum urokinase plasminogen activator receptor and liver stiffness in postoperative biliary atresia. (27957246)
2016
32
Multiple orifices and cholangiography with a "fire-like" appearance after Kasai hepatoportoenterostomy for biliary atresia. (27502010)
2016
33
Association between rs17095355 polymorphism on 10q24 and susceptibility to biliary atresia: a meta-analysis. (27557278)
2016
34
The SRL peptide of rhesus rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia. (27859498)
2016
35
Ichthyosis congenita with biliary atresia: a rare association. (27824632)
2016
36
Classification of biliary atresia in the laparoscopic era. (27655364)
2016
37
The extended Kasai portoenterostomy for biliary atresia: A preliminary report. (27046977)
2016
38
Liver transplantation in infants with biliary atresia: comparison of primary versus temporary abdominal closure. (27812908)
2016
39
Role of CD56-expressing immature biliary epithelial cells in biliary atresia. (26937142)
2016
40
FOXP3 PROMOTOR METHYLATION IMPAIRS SUPPRESSIVE FUNCTION of REGULATORY T CELLS in BILIARY ATRESIA. (27659419)
2016
41
Biliary Atresia: Indications and Timing of Liver Transplantation and Optimization of Pre-Transplant Care. (27650268)
2016
42
Impaired intention-to-treat survival after listing for liver transplantation in children with biliary atresia compared to other chronic liver diseases: 20A years' experience from the Nordic countries. (27957786)
2016
43
Analysis of the prognostic factors of long-term native liver survival in survivors of biliary atresia. (27464487)
2016
44
Biliary atresia: Where do we stand now? (28083081)
2016
45
Hepatoblastoma in Explanted Livers of Patients With Biliary Atresia. (27457778)
2016
46
Ultrasound for the Diagnosis of Biliary Atresia: A Meta-Analysis. (27010179)
2016
47
Seventeen years of Kasai portoenterostomy for biliary atresia in a single Southeast Asian paediatric centre. (27859955)
2016
48
Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT. (26901874)
2016
49
Effect of microRNA-155 on the interferon-gamma signaling pathway in biliary atresia. (27817193)
2016
50
Liquid chromatography-mass spectroscopy as a tool in the rapid diagnosis of biliary atresia: a pilot study. (26995515)
2016

Variations for Biliary Atresia

About this section

Expression for genes affiliated with Biliary Atresia

About this section
Search GEO for disease gene expression data for Biliary Atresia.

Pathways for genes affiliated with Biliary Atresia

About this section

GO Terms for genes affiliated with Biliary Atresia

About this section

Cellular components related to Biliary Atresia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.9ALB, HGF, TGFB1, TIMP1
2proteinaceous extracellular matrixGO:00055788.9CTGF, GPC1, MMP7, TGFB1, TIMP1
3extracellular spaceGO:00056158.1ALB, CTGF, GPC1, GPT, HGF, MMP7
4extracellular regionGO:00055767.4ALB, CFC1, CTGF, GPC1, HGF, JAG1

Biological processes related to Biliary Atresia according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1cell activationGO:000177510.6TGFB1, TIMP1
2extracellular matrix disassemblyGO:002261710.1MMP7, SPP1, TIMP1
3agingGO:000756810.1CTGF, MMP7, TGFB1, TIMP1
4bile acid and bile salt transportGO:001572110.0ALB, NR1H4, SLC10A1, SLC10A2
5Notch signaling pathwayGO:000721910.0JAG1, NR1H4, TGFB1
6response to organic substanceGO:00100339.9SPP1, TGFB1, TIMP1
7response to vitamin DGO:00332809.9SPP1, TGFB1
8platelet degranulationGO:00025769.8ALB, HGF, TGFB1, TIMP1

Molecular functions related to Biliary Atresia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1bile acid:sodium symporter activityGO:000850810.6SLC10A1, SLC10A2
2growth factor activityGO:00080838.8CTGF, HGF, JAG1, TGFB1, TIMP1

Sources for Biliary Atresia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet